See also this year's filing and all EDGAR filings for this company.
PDF Report 0001430306_2019_Tonix_Pharmaceuticals_Holding_Corp.pdf
Logs
| warning | Missing logo | subcommand.report | {} |
| info | Failed to set obs_EconomicCapitalRatio | industry.us_generic | {'reason': "KeyError('0001430306')"} |
| info | Added remainder_ComprehensiveNetIncome directly from 10K | industry.us_generic | {} |
Graph
Absolute values for 0001430306, Tonix Pharmaceuticals Holding Corp.
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 26,056,000 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 120,000 |
| 2 | PropertyPlantAndEquipmentNet | 43,000 |
| 3 | remainder_Assets | 100,000 |
| 4 | LiabilitiesCurrent | 2,655,000 |
| 5 | LiabilitiesNoncurrent | 0 |
| 6 | remainder_Liabilities | 0 |
| 7 | CostOfGoodsAndServicesSold | 0 |
| 8 | SellingGeneralAndAdministrativeExpense | 8,764,000 |
| 9 | ResearchAndDevelopmentExpense | 17,558,000 |
| 10 | remainder_Expenses | 0 |
| 11 | remainder_Revenues | 0 |
| 12 | remainder_NetIncome | 233,000 |
| 13 | remainder_ComprehensiveNetIncome | -29,000 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 26,319,000 |
| 1 | Liabilities | 2,655,000 |
| 2 | Expenses | 26,322,000 |
| 3 | Revenues | 0 |
| 4 | StockholdersEquity | 23,664,000 |
| 5 | NetIncome | -26,089,000 |
| 6 | ComprehensiveNetIncome | -26,103,500 |
| 7 | BaseVar | 27,779,000 |
| 8 | EconomicCapitalRatio | 1.01 |
Edgar->Model Mapping
Feature Distribution
Change over Time
